Literature DB >> 19030270

Understanding clinical trials in childhood cancer.

Mason C Bond1, Sheila Pritchard.   

Abstract

Clinical trials in paediatric cancer continue to be a key factor in progress toward better treatment and prognosis. Paediatricians and family physicians may be asked by patients and families for their advice regarding participation in such trials. The significant advances in the success of treatment of paediatric cancer have come, in part, from the high participation rate of patients in such studies. The present article reviews the definitions and goals of phase 1, 2 and 3 trials. A known and trusted physician or paediatrician can be helpful in conjunction with the oncologist in guiding patients and their families and helping them understand the risks and benefits of participation in clinical trials.

Entities:  

Keywords:  Cancer; Children; Trials

Year:  2006        PMID: 19030270      PMCID: PMC2435316     

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  11 in total

1.  The "inclusion benefit" in clinical trials.

Authors:  J D Lantos
Journal:  J Pediatr       Date:  1999-02       Impact factor: 4.406

2.  Childhood cancer survival trends in Europe: a EUROCARE Working Group study.

Authors:  Gemma Gatta; Riccardo Capocaccia; Charles Stiller; Peter Kaatsch; Franco Berrino; Monica Terenziani
Journal:  J Clin Oncol       Date:  2005-06-01       Impact factor: 44.544

3.  The national impact of clinical cooperative group trials for pediatric cancer.

Authors:  S B Murphy
Journal:  Med Pediatr Oncol       Date:  1995-05

Review 4.  Developmental therapeutics in childhood cancer. A perspective from the Children's Oncology Group and the US Food and Drug Administration.

Authors:  M L Bernstein; G H Reaman; S Hirschfeld
Journal:  Hematol Oncol Clin North Am       Date:  2001-08       Impact factor: 3.722

5.  Conduct of phase I trials in children with cancer.

Authors:  M Smith; M Bernstein; W A Bleyer; J D Borsi; P Ho; I J Lewis; A Pearson; F Pein; C Pratt; G Reaman; R Riccardi; N Seibel; R Trueworthy; R Ungerleider; G Vassal; T Vietti
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

Review 6.  The U.S. pediatric cancer clinical trials programmes: international implications and the way forward.

Authors:  W A Bleyer
Journal:  Eur J Cancer       Date:  1997-08       Impact factor: 9.162

Review 7.  Clinical trials in children.

Authors:  Patrina H Y Caldwell; Sharon B Murphy; Phyllis N Butow; Jonathan C Craig
Journal:  Lancet       Date:  2004 Aug 28-Sep 3       Impact factor: 79.321

Review 8.  Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review.

Authors:  Jeffrey M Peppercorn; Jane C Weeks; E Francis Cook; Steven Joffe
Journal:  Lancet       Date:  2004-01-24       Impact factor: 79.321

9.  Perceptions of cancer patients and their physicians involved in phase I trials.

Authors:  C Daugherty; M J Ratain; E Grochowski; C Stocking; E Kodish; R Mick; M Siegler
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

10.  Informed consent in the Childrens Cancer Group: results of preliminary research.

Authors:  E D Kodish; R D Pentz; R B Noll; K Ruccione; J Buckley; B J Lange
Journal:  Cancer       Date:  1998-06-15       Impact factor: 6.860

View more
  10 in total

1.  Predictors of Success of Phase II Pediatric Oncology Clinical Trials.

Authors:  Laura Franshaw; Maria Tsoli; Jennifer Byrne; Chelsea Mayoh; Siva Sivarajasingam; Murray Norris; Glenn M Marshall; David S Ziegler
Journal:  Oncologist       Date:  2019-02-26

2.  The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.

Authors:  Joseph M Unger; Elise Cook; Eric Tai; Archie Bleyer
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

3.  Population-based survival estimates for childhood cancer in Australia during the period 1997-2006.

Authors:  P D Baade; D R Youlden; P C Valery; T Hassall; L Ward; A C Green; J F Aitken
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

Review 4.  Understanding and addressing the lack of clinical trial enrollment among adolescents with cancer.

Authors:  Eric Tai; Natasha Buchanan; Dena Eliman; Lauren Westervelt; Lynda Beaupin; Silvana Lawvere; Archie Bleyer
Journal:  Pediatrics       Date:  2014-06       Impact factor: 7.124

Review 5.  Communication Skills Training in Pediatric Oncology: Moving Beyond Role Modeling.

Authors:  Angela M Feraco; Sarah R Brand; Jennifer W Mack; Jennifer C Kesselheim; Susan D Block; Joanne Wolfe
Journal:  Pediatr Blood Cancer       Date:  2016-01-29       Impact factor: 3.167

6.  Incidence of childhood cancer in Canada during the COVID-19 pandemic.

Authors:  Marie-Claude Pelland-Marcotte; Lin Xie; Randy Barber; Sulaf Elkhalifa; Mylene Frechette; Jaskiran Kaur; Jay Onysko; Eric Bouffet; Conrad V Fernandez; David Mitchell; Meera Rayar; Alicia Randall; David Stammers; Valérie Larouche; Alexandra Airhart; Miranda Fidler-Benaoudia; Sarah Cohen-Gogo; Lillian Sung; Paul Gibson
Journal:  CMAJ       Date:  2021-11-29       Impact factor: 8.262

7.  Complementary and alternative medicine modalities used to treat adverse effects of anti-cancer treatment among children and young adults: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Dana C Mora; Grete Overvåg; Miek C Jong; Agnete E Kristoffersen; Debbie C Stavleu; Jianping Liu; Trine Stub
Journal:  BMC Complement Med Ther       Date:  2022-04-02

8.  Safety of Complementary and Alternative Medicine (CAM) treatment among children and young adults who suffer from adverse effects of conventional cancer treatment: A systematic review.

Authors:  Dana C Mora; Agnete E Kristoffersen; Grete Overvåg; Miek C Jong; Marit Mentink; Jianping Liu; Trine Stub
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

9.  Development of an evidence-based decision aid on complementary and alternative medicine (CAM) and pain for parents of children with cancer.

Authors:  Miek C Jong; Inge Boers; Herman van Wietmarschen; Martine Busch; Marianne C Naafs; Gertjan J L Kaspers; Wim J E Tissing
Journal:  Support Care Cancer       Date:  2019-09-06       Impact factor: 3.603

10.  Unseen and unheard: African children with cancer are consistently excluded from clinical trials.

Authors:  Emmanuella Amoako; Desmond Tanko Jumbam; Yaw Bediako
Journal:  BMJ Glob Health       Date:  2021-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.